The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
LDDD · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | LDDD | LMAT | VLTO | VRTX |
|---|---|---|---|---|
| Moat Score (0–100) | 76 | 78 (highest) | 77 | 76 |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 70 | 96 (highest) | 72 | 73 |
| Pricing power | 91 | 99 | 97 | 100 (highest) |
| Returns on capital | — | 62 | 100 (highest) | 96 |
| Balance-sheet safety | 100 (highest) | 55 | 77 | 73 |
| Capital discipline | 44 | 78 (highest) | 42 | 39 |
| Price vs. high estimate | No price data | 289% above high estimate | 131% above high estimate | 104% above high estimate (largest discount to high estimate) |
| Market cap | $15.3M | $2.3B | $23.1B | $122.0B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |